---
title: "Vanda Pharmaceuticals Announces Participation in the B. Riley Securities 2026 Mind, Muscle & Vision Summit | VNDA Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292355973.md"
description: "Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) announced it will participate in a fireside chat at the B. Riley Securities Mind, Muscle & Vision Summit in Boston on July 16, 2026."
datetime: "2026-07-10T12:30:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292355973.md)
  - [en](https://longbridge.com/en/news/292355973.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292355973.md)
---

# Vanda Pharmaceuticals Announces Participation in the B. Riley Securities 2026 Mind, Muscle & Vision Summit | VNDA Stock News

, /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate in a fireside chat at the B. Riley Securities Mind, Muscle & Vision Summit in Boston, Massachusetts on Thursday, July 16, 2026.

**About Vanda Pharmaceuticals Inc.**

Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com and follow us on X @vandapharma.

**Corporate Contact:  
**Kevin Moran  
Senior Vice President, Chief Financial Officer and Treasurer  
Vanda Pharmaceuticals Inc.  
202-734-3400  
pr@vandapharma.com

Jim Golden / Jack Kelleher / Dan Moore  
Collected Strategies  
VANDA-CS@collectedstrategies.com

SOURCE Vanda Pharmaceuticals Inc.

### Related Stocks

- [VNDA.US](https://longbridge.com/en/quote/VNDA.US.md)
- [RILY.US](https://longbridge.com/en/quote/RILY.US.md)
- [RILYL.US](https://longbridge.com/en/quote/RILYL.US.md)
- [RILYG.US](https://longbridge.com/en/quote/RILYG.US.md)
- [RILYN.US](https://longbridge.com/en/quote/RILYN.US.md)
- [RILYK.US](https://longbridge.com/en/quote/RILYK.US.md)
- [RILYP.US](https://longbridge.com/en/quote/RILYP.US.md)
- [RILYZ.US](https://longbridge.com/en/quote/RILYZ.US.md)
- [RILYT.US](https://longbridge.com/en/quote/RILYT.US.md)

## Related News & Research

- [VNDA: Fanapt® sales surged, BYSANTI™ gained FDA approval, and NEREUS™ launched in Q2 2026](https://longbridge.com/en/news/295007537.md)
- [Vanda Pharmaceuticals Q2 loss widens on lower sales, higher costs](https://longbridge.com/en/news/295007325.md)
- [Vanda Pharmaceuticals' (VNDA) Buy Rating Reaffirmed at B. Riley Financial](https://longbridge.com/en/news/295434930.md)
- [B. Riley Securities Initiates a Buy Rating on AvePoint (AVPT)](https://longbridge.com/en/news/295241864.md)
- [B. Riley Securities Keeps Their Buy Rating on Harrow Health (HROW)](https://longbridge.com/en/news/295421123.md)